Stereotaxis Launches Interface between Niobe ES System and Philips’ X-Ray System

Stereotaxis Inc., a leader in robotic technologies for the treatment of cardiac arrhythmias, has released an interface between its remote magnetic navigation system for electrophysiology (EP) procedures and the Philips Allura Xper FD10 cardiovascular X-ray system. The interface allows interoperability of the Stereotaxis Niobe system with the Philips Allura Xper FD10 version R8.2 system and is available worldwide.
 
“The seamless integration of our two platforms further optimizes EP procedures by providing state-of-the-art fluoroscopic visualization with enhanced managed X-ray doses,” said William C. Mills, CEO and chairman. “The combination of our advanced technologies facilitates physicians in delivering therapy safely, quickly and accurately for the benefit of patients. We will continue to identify and build strategic alliances with industry leaders such as Philips to bring distinctive solutions to the practice of interventional medicine.”
 
The Allura Xper FD10 is a ceiling-suspended imaging system widely used for EP and other cardiac interventions. The system offers rotational scan for high-resolution 3D images of cardiac anatomy in real-time, managed X-ray, and storage and retrieval of multi-modality cardiology information.
 
St. Louis, Mo.-based Stereotaxis develops robotic cardiology instrument navigation systems that enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. More than 100 issued patents support the Stereotaxis platform, which helps physicians worldwide provide patient care with robotic precision and safety, improve lab efficiency and productivity, and enhance integration of procedural information. Stereotaxis’ core Epoch Solution includes the Niobe magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management solutions, and the Vdrive robotic navigation system and consumables.
 
The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union.